HTA155 The Impact of Phase 2 Clinical Trials on Reimbursement Recommendations in Oncology By Canadian Health Technology Assessment Agencies
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1839
https://www.valueinhealthjournal.com/article/S1098-3015(23)04969-0/fulltext
Title :
HTA155 The Impact of Phase 2 Clinical Trials on Reimbursement Recommendations in Oncology By Canadian Health Technology Assessment Agencies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04969-0&doi=10.1016/j.jval.2023.09.1839
First page :
Section Title :
Open access? :
No
Section Order :
11275